bispecific antibody JNJ-70218902
Term · Oncology and biomedicine · MLC-T-ONC-012038
A T-cell redirecting agent and bispecific antibody targeting an as of yet undisclosed tumor-associated antigen (TAA) expressed on tumor cells and the CD3 receptor complex expressed on T cells, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody JNJ-70218902 binds to both CD3 on T cells and a TAA expressed on tumor cells. The resulting cross-linkage activates and redirects T cells to the TAA-expressing tumor cells. This results in T-cell-mediated lysis of tumor cells.
| Identifier | MLC-T-ONC-012038 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | T-cell-redirecting agent JNJ-70218902 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012038",
"term": "bispecific antibody JNJ-70218902",
"field": "Oncology and biomedicine",
"definition": "A T-cell redirecting agent and bispecific antibody targeting an as of yet undisclosed tumor-associated antigen (TAA) expressed on tumor cells and the CD3 receptor complex expressed on T cells, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody JNJ-70218902 binds to both CD3 on T cells and a TAA expressed on tumor cells. The resulting cross-linkage activates and redirects T cells to the TAA-expressing tumor cells. This results in T-cell-mediated lysis of tumor cells.",
"synonyms": [
"T-cell-redirecting agent JNJ-70218902"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bispecific-antibody-jnj-70218902/"
}
Record 3,615 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.